Latest News

House GOP escalates war on Justice Dept. as members flock to Trump trial

The Republican chairs of the powerful House Judiciary and Oversight committees slammed the Biden administration this week, accusing the president and Attorney General Merrick Garland of politicizing the justice system.

But as Reps. Jim Jordan (R-Ohio) and James Comer (R-Ky.) pilloried the White House and the Justice Department, their committees were hobbled by attendance problems: At least five members were in New York on Thursday morning, standing behind former president Donald Trump at his criminal trial and inserting themselves, and their political views, into the same justice system the two chairmen claimed to be defending from politicization.

This post appeared first on The Washington Post

You May Also Like

Editor's Pick

ERP or Enterprise Resource Planning solutions help businesses of all sizes manage their daily business operations. First used in the 1990s, ERP systems have...

Investing

Democratic Gov. Janet Mills on Wednesday vetoed a bill aimed at prohibiting foreign influence in Maine elections, but voters will get the final say...

Latest News

There were several reasons offered in support of the congestion pricing plan that was supposed to go into effect in New York at the...

Latest News

House Speaker Mike Johnson (R-La.) on Wednesday appointed Reps. Scott Perry (R-Pa.) and Ronny Jackson (R-Tex.), two Trump loyalists who denied the results of...

Disclaimer: realinvestmentstar.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 realinvestmentstar.com